National and Kapodistrian University of Athens
Proteomics in pregnancy-associated breast cancer and outcome evaluation in patients and neonates
Abstract
dc:descriptionBackground: Pregnancy-associated breast cancer (PABC) represents one of the most frequently diagnosed pregnancy-related types of malignancy characterized by notably rising incidence. There is a significant lack of data available in the literature regarding PABC proteome and underlying pathophysiology. Additionally, neonatal outcome and long-term pediatric development after in-utero exposure to PABC and cancer management require further investigation as existing data remain scarce. Materials & Methods: Proteomic techniques, including immunohistochemistry (IHC), two-dimensional gel electrophoresis (2-DGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were applied to evaluate implications of Hippo signaling pathway de-regulation in PABC tumorigenesis and to further explore PABC serum proteomic signatures. Furthermore, the International Network on Cancer, Infertility and Pregnancy (INCIP) registry protocol was employed to assess the impact prenatal exposure to PABC and chemotherapy administration may have on fetal growth, neonatal outcome and long-term pediatric development. Results: The immunohistochemical analysis on YAP1 and TAZ expression in PABC carcinogenesis and metastasis included 21 formalin-fixed paraffin embedded (FFPE) tissue samples. Strong nuclear YAP1/TAZ staining was reported in 48% of the PABC patients examined and hormone receptor (HR) negative status was statistically associated with Hippo signaling pathway de-regulation. No correlation was observed with the overall survival (OS) and the disease-free survival (DFS) rate. Furthermore, high-throughput proteomic techniques (e.g., 2-DGE, MALDI-TOF-MS) identified a panel of 53 differentially expressed serum proteins with diverse biological roles and various functional interactions among 5 PABC patients, 5 matched non-PABC patients, and 5 matched healthy pregnant controls analyzed. Most of the differentially expressed proteins in PABC patients were involved in biological mechanisms known to be interrupted in oncogenesis such as cellular process (20.8%), localization (14.6%), biological regulation (12.5%), metabolic process (8.3%), response to stimulus (8.3%), and immune system process (6.3%). Moreover, 5 children in-utero exposed to PABC and cancer management were evaluated in our study (clinical examination, ECG and echocardiogram, brain MRI, and/or neuropsychological testing) and no aberrant findings were reported. Conclusion: PABC demonstrates differential proteomic expression and distinct clinical and molecular features. The identification of PABC-related proteomic biomarkers may offer novel targets for early diagnosis and optimal management. Lastly, vigilant monitoring of neonatal and pediatric outcome after prenatal exposure to PABC is essential to formulate definite clinical practice guidelines and provide valuable patient counseling.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Korakiti, Anna-Maria
- Κορακίτη, Άννα-Μαρία
Subjects
dc:subject × 21- Καρκίνος του μαστού σχετιζόμενος με την κύηση
- Πρωτεωμική ανάλυση
- Φασματομετρία μάζας
- Βιοδείκτες ορού
- Εμβρυική έκθεση σε χημειοθεραπεία
- Μητρικός καρκίνος
- Pregnancy-associated breast cancer
- Proteomics
- Immunohistochemistry (IHC)
- Mass spectrometry
- Serum biomarkers
- In-utero exposure to chemotherapy
- Maternal cancer
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ογκολογία
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Oncology
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57864